Biomerica

BMRANasdaq United States Health Care Biotechnology: In Vitro & In Vivo Diagnostic Substances

Market cap

$7.404 M

$1.61 -3.59%

Close of 6 Nov 2026

As of 6 Nov 2026, Biomerica (BMRA) has a market capitalization of $7.40M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$4.45M

#3289 by revenue

Earnings

-$3.77M

Loss-making

Shares outstanding

4,598,968

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: In Vitro & In Vivo Diagnostic Substances, ranked by market cap

All 19 →

#12ImmucellICCC$89.7M
#13Insight Molecular DiagnosticsIMDX$79.2M
#14BiomericaBMRA$7.40M
#15VolitionrxVNRX$5.84M
#16Cardio DiagnosticsCDIO$5.16M

What if Biomerica were worth as much as…

Open the what-if tool →

Gold $28.2T

$6,139,829

Per share 3,813,558× higher

Bitcoin $1.53T

$332,215.44

Per share 206,345× higher

Apple $5.02T

$1,090,632

Per share 677,411× higher

Or at a round number

$10.0M $20.0M $50.0M $100.0M

Where these numbers come from

Share counts and financials for Biomerica are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.